Paper Details

  1. Home
  2. Paper Details

Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression.

Author: BruijnzeelDawn, TandonRajiv

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This review discusses the pharmacology, clinical trial data, and efficacy and side effects of brexpiprazole, a recently introduced antipsychotic agent approved for the treatment of schizophrenia and as an adjunct for treatment of major depressive disorder.
Paper Details　
Original Abstract of the Article :
Antipsychotic agents, utilized for the treatment of a range of psychiatric disorders, differ substantially in terms of their pharmacology and adverse effect profiles. Incomplete and variable efficacy, differences in safety-tolerability, and highly heterogeneous response across individuals prompt dev...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869657/

データ提供：米国国立医学図書館（NLM）

Brexpiprazole: A New Oasis in the Desert of Psychiatric Disorders

Schizophrenia and major depressive disorder are challenging psychiatric conditions that can feel like a vast and unforgiving desert. This review explores the potential of brexpiprazole, a new antipsychotic agent, to provide relief for individuals struggling with these disorders.

A Novel Approach: Exploring a New Pathway to Treatment

This review explores the unique pharmacological profile of brexpiprazole, highlighting its potent activity at various receptors in the brain. The researchers discuss the potential of this drug to effectively treat schizophrenia and major depressive disorder, offering a new pathway to alleviate suffering.

A Promising Outlook: Navigating the Desert of Mental Health

This review highlights the potential of brexpiprazole to improve the lives of individuals struggling with schizophrenia and major depressive disorder. The researchers suggest that brexpiprazole may offer a new oasis of hope for these patients, providing relief from the debilitating symptoms of their conditions.

Dr. Camel’s Conclusion

This review offers a glimpse into the potential of brexpiprazole to provide a new oasis in the desert of psychiatric disorders. The unique pharmacological profile of this drug suggests a promising approach to treating schizophrenia and major depressive disorder. As researchers continue to explore the benefits of brexpiprazole, there is a growing hope that this drug may offer a path to relief for those navigating the challenges of these complex mental health conditions.

Date :
  1. Date Completed 2017-05-08
  2. Date Revised 2023-11-11
Further Info :

Pubmed ID

27274197

DOI: Digital Object Identifier

PMC4869657

Related Literature

Article Analysis
・Side Effects of brexpiprazole
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.